| Dr Thomas John Davidson Iv, DPM | |
|
1331 Hamilton Ter Se, Roanoke, VA 24014-1805 | |
| (251) 747-4401 | |
| Not Available |
| Full Name | Dr Thomas John Davidson Iv |
|---|---|
| Gender | Male |
| Speciality | Podiatrist - Primary Podiatric Medicine |
| Location | 1331 Hamilton Ter Se, Roanoke, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295171858 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213EP1101X | Podiatrist - Primary Podiatric Medicine | SC006438 (Pennsylvania) | Primary |
| Provider Name | Thomas J Davidson Iv Wny Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1013697770 PECOS PAC ID: 9638531551 Enrollment ID: O20230809002701 |
News Archive
Fentanyl use by people who use drugs has doubled since 2015, and two-thirds of people are aware they've taken it, finds new research out of British Columbia, the Canadian province that has experienced the highest number of illicit drug toxicity deaths as a result of the opioid crisis.
In the January 18th issue of Molecular Cell, Case Western Reserve University School of Medicine researcher Kristian E. Baker, Ph.D. challenges molecular biology's established body of evidence and widely-accepted model for nonsense-mediated messenger ribonucleic acid (mRNA) decay.
The study entitled "Long term extension of a randomized controlled trial of probiotics using electronic health records" led by researchers in the Swansea University Medical School and the College of Human and Health Sciences, was published in Scientific Reports.
A CMS official last week said that the agency on Jan. 1 will suspend the Competitive Acquisition Program, launched in 2006 to supply certain medications to physician offices, because of "contractual issues" related to proprietary data, CQ HealthBeat reports.
Glioblastoma multiforme is among the most aggressive and difficult cancers to treat. Now, researchers at Penn State University have shown that a lipid-based nanoparticle, designed to bind to a specific receptor found on malignant brain cells but not healthy ones, improves the potency of a common anticancer drug and slows significantly the growth of glioblastoma in mice.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas John Davidson Iv, DPM 1331 Hamilton Ter Se, Roanoke, VA 24014-1805 Ph: (251) 747-4401 | Dr Thomas John Davidson Iv, DPM 1331 Hamilton Ter Se, Roanoke, VA 24014-1805 Ph: (251) 747-4401 |
News Archive
Fentanyl use by people who use drugs has doubled since 2015, and two-thirds of people are aware they've taken it, finds new research out of British Columbia, the Canadian province that has experienced the highest number of illicit drug toxicity deaths as a result of the opioid crisis.
In the January 18th issue of Molecular Cell, Case Western Reserve University School of Medicine researcher Kristian E. Baker, Ph.D. challenges molecular biology's established body of evidence and widely-accepted model for nonsense-mediated messenger ribonucleic acid (mRNA) decay.
The study entitled "Long term extension of a randomized controlled trial of probiotics using electronic health records" led by researchers in the Swansea University Medical School and the College of Human and Health Sciences, was published in Scientific Reports.
A CMS official last week said that the agency on Jan. 1 will suspend the Competitive Acquisition Program, launched in 2006 to supply certain medications to physician offices, because of "contractual issues" related to proprietary data, CQ HealthBeat reports.
Glioblastoma multiforme is among the most aggressive and difficult cancers to treat. Now, researchers at Penn State University have shown that a lipid-based nanoparticle, designed to bind to a specific receptor found on malignant brain cells but not healthy ones, improves the potency of a common anticancer drug and slows significantly the growth of glioblastoma in mice.
› Verified 3 days ago
Shenandoah Valley Podiatry Associates, Ltd. Podiatrist Medicare: Medicare Enrolled Practice Location: 60 Summerfield Ct, Suite 102, Roanoke, VA 24019 Phone: 540-904-1458 Fax: 855-495-0994 | |
Mr. David Lamont Nielson, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 222 Walnut Ave Sw, Roanoke, VA 24016 Phone: 540-344-3668 Fax: 540-769-6381 | |
Wesley Maurice Leong, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1906 Belleview Ave Se, Roanoke, VA 24014 Phone: 540-981-7000 | |
Dr. Peter F Kelly, D.P.M. Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 4106 Electric Rd, Roanoke, VA 24014 Phone: 540-989-3338 Fax: 540-989-5425 | |
Dr. Craig Alan Wilhelms, DPM, PC Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3 Riverside Cir, Roanoke, VA 24016 Phone: 540-510-6200 Fax: 540-857-5306 | |
Jennifer Anne Keller, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 60 Summerfield Ct, Suite 102, Roanoke, VA 24019 Phone: 540-904-1458 Fax: 855-495-0994 | |
Dr. Marc A. Platt, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3 Riverside Cir, Roanoke, VA 24016 Phone: 540-725-1226 Fax: 540-857-5306 |